Onconic Therapeutics Receives MFDS Approval for JAQBO, a New Treatment for Gastroesophageal Reflux Disease
Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.uk
View original content:https://www.prnewswire.co.uk/news-releases/onconic-therapeutics-receives-mfds-approval-for-jaqbo-a-new-treatment-for-gastroesophageal-reflux-disease-gerd-302127478.html
en | boerse | 67923470 |
